Evidence map›Paper›PMID 31426786›Full record

ArticleBMC health services research2019

A cross-sectional study: medication safety among cancer in-patients in tertiary care hospitals in KPK, Pakistan.

Marium Azim, Ahmad Khan, Tahir Mehmood Khan, Mohammad Kamran

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in BMC health services research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Use of Failure Mode and Effects Analysis (FMEA) for Risk Analysis of Drug Use in Patients with Lung Cancer.International journal of environmental research and public health · 2022
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Marium AzimQuaid-I-Azam University, QAU Islamabad, Islamabad, Pakistan. marium@bs.qau.edu.pk.ORCID http://orcid.org/0000-0002-2479-7726
Ahmad KhanDepartment of Pharmacy, Qauid-I-Azam University, QAU Islamabad, Islamabad, Pakistan.
Tahir Mehmood KhanInstitute of Pharmaceutical Science, UVAS Lahore, Lahore, Pakistan.
Mohammad KamranRiphah International University Islamabad, Islamabad, Pakistan.
Quaid-i-Azam University · PKRiphah International University · PK

Funding

None None
6 · The paper itself

Abstract

backgroundMedication safety in cancer patients receiving complex medication regimens is an important problem in various settings. Medication related events, interceptions and interventions are not well described in this area. We intended to study incidence, types, settings and stages involved, root cause analysis, medication classes involved and the level of harm cause by medication errors in two hospitals providing oncology services comparatively. The severity of incidents and interventions are studied.

methodsIt was a prospective cross sectional study among cancer in-patients of two tertiary care hospitals of KPK. Scale by NCC-MERP was used for evaluation of all medication related incidents. The data obtained was analyzed by IBM SPSS statistics 22 with 95% confidence interval and used the same for other descriptive statistics.

resultsAll medication orders were reviewed at both sites (Computerized Prescription Order Entry and HWP systems). Potential ADEs incidence was found high at site 2 (97.5%) while medication errors without harm was high at site 1 (97.5%). Most events occur at prescribing level 87.6 and 81.7% at both sites 1 and 2. Types highly reported involved improper dose 31.4 and 15.5%, monitoring error 14.6 and 15.2% at site 1 and 2. Medications involved in these incidents were antibiotics 44 and 12.7%, antiemetic 7.5 and 15.8% and antineoplastic 2.9 and 9.4% at site 1 and 2. Severity of 3.6 and 36.5% incidents had potential to cause harm at site 1 and 2. Root causes were human factors 62.6 and 72.3%, drug selection 33.6 and 38.8%, and dose selection 39.6 and 15.3% at sites 1 and 2. Contributing factors including staff training 33.6 and 24.3%, system for covering patient care 14.9 and 36.6%, communication system 2.4 and 20.3%, interruptions 9.7 and 7.3% and others 78.8 and 68.6% were highly reported. Preventability of medication errors was 99% at both sites. Intervention was taken in 90.5% events at site 1 (CPOE system) while the incidence lowest at site 2 (HWP system).

conclusionMedication related events are high among cancer in-patients at the site lacking updated electronic system for medication prescribing. Proper training about medication safety, reporting and interventions are required.

Indexed as

Anti-Bacterial AgentsAntiemeticsAntineoplastic AgentsCross-Sectional StudiesDrug PrescriptionsDrug-Related Side Effects and Adverse ReactionsHumansIncidenceMedication ErrorsNeoplasmsPakistanProspective StudiesRoot Cause AnalysisTertiary Care CentersAnti-Bacterial AgentsAntiemeticsAntineoplastic AgentsChemotherapyContributing factorsInterventionsMedication related eventsMedication safetyPotential ADEsRoot cause analysis

Identifiers

PMID31426786
PMCPMC6699127
OpenAlexW2968490567

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.